Alexander W. Tarr

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Veterinary Medicine, Immunology, Immunization +16

Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge

Mansun Law, Toshiaki Maruyama, Jamie Lewis et al. · Nature Medicine · 2007 · 592 citations

Veterinary Medicine, Immunology, Infectious Diseases +12

Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein

Ania M. Owsianka, Alexander W. Tarr, Vicky S. Juttla et al. · Journal of Virology · 2005 · 283 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Characterization of host‐range and cell entry properties of the major genotypes and subtypes of hepatitis C virus†

Dimitri Lavillette, Alexander W. Tarr, Cécile Voisset et al. · Hepatology · 2005 · 259 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17